journal article·2020-03-11

Nanomedicine toward 2040

Joseph J. Richardson, Frank Caruso

Nano Letters· Volume 20· Issue 3
Publisher page

Abstract

Nanomedicine as a research field has existed for about two decades, and it is therefore timely to discuss what the next 20 years in nanomedicine should accomplish to provide a scientifically grounded framework for sustained success. To further advance nanomedicine, emphasis should be on integration of hypothesis-driven research principles of medicine with the industrially relevant design principles of nanomaterials. The recently emerging but significantly successful field of immuno-oncology serves as an example of how fundamental research leads to translational success: mechanisms of action are first determined, followed by target molecule identification, and finally in vivo testing with appropriately designed and controlled studies.(1) From the materials science perspective, the rapid development of photovoltaics demonstrates how reproducibility is important to allow for field-wide objective comparisons to be made prior to industrial adoption.(2) The nanomedicine field could also benefit from delineating more clearly whether a study is addressing fundamental or translational questions.(3) Both should be encouraged, but focused, rigorous, and reproducible study designs are essential to facilitate scientific advances as well as comparative studies aimed at commercial outcomes.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoparticles: synthesis and applications · Artificial Intelligence in Healthcare and Education · Graphene and Nanomaterials Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, Department of Chemical Engineering, The University of Melbourne, Parkville, Victoria 3010, Australia

Funding

National Health and Medical Research Council · Australian Research Council Centre of Excellence in Convergent Bio-Nano Science and Technology

References (11)

Show source-provided references
1. 10.1038/s41551-018-0314-y10.1038/s41551-018-0314-y ↗
2. 10.1126/science.120016510.1126/science.1200165 ↗
3. 10.1038/s41565-019-0597-510.1038/s41565-019-0597-5 ↗
4. 10.1016/j.nantod.2019.06.00410.1016/j.nantod.2019.06.004 ↗
5. 10.1038/s41565-018-0246-410.1038/s41565-018-0246-4 ↗
6. Strovel J. · 2012
7. 10.1007/s12247-008-9043-110.1007/s12247-008-9043-1 ↗
8. 10.1016/j.jchromb.2006.07.03710.1016/j.jchromb.2006.07.037 ↗
9. 10.1186/s12645-019-0055-y10.1186/s12645-019-0055-y ↗
10. 10.1021/acs.nanolett.9b0409010.1021/acs.nanolett.9b04090 ↗
11. 10.1021/cm502594j10.1021/cm502594j ↗